Market Research Logo

Transcatheter Aortic Valves (TAVI) - Medical Devices Pipeline Assessment, 2017

Transcatheter Aortic Valves (TAVI) - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Transcatheter Aortic Valves (TAVI) - Medical Devices Pipeline Assessment, 2017 provides an overview of Transcatheter Aortic Valves (TAVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Aortic Valves (TAVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Aortic Valves (TAVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valves (TAVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valves (TAVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Transcatheter Aortic Valves (TAVI) Overview
  • Products under Development
    • Transcatheter Aortic Valves (TAVI) - Pipeline Products by Stage of under Development
      • Table figure 1: Transcatheter Aortic Valves (TAVI) - Pipeline Products by Stage of under Development
      • Table Transcatheter Aortic Valves (TAVI) - Pipeline Products by Stage of under Development
    • Transcatheter Aortic Valves (TAVI) - Pipeline Products by Territory
      • Table figure 2: Transcatheter Aortic Valves (TAVI) - Pipeline Products by Territory
      • Table Transcatheter Aortic Valves (TAVI) - Pipeline Products by Territory
    • Transcatheter Aortic Valves (TAVI) - Pipeline Products by Regulatory Path
      • Table figure 3: Transcatheter Aortic Valves (TAVI) - Pipeline Products by Regulatory Path
      • Table Transcatheter Aortic Valves (TAVI) - Pipeline Products by Regulatory Path
    • Transcatheter Aortic Valves (TAVI) - Pipeline Products by Estimated Approval Date
      • Table figure 4: Transcatheter Aortic Valves (TAVI) - Pipeline Products by Estimated Approval Date
      • Table Transcatheter Aortic Valves (TAVI) - Pipeline Products by Estimated Approval Date
    • Transcatheter Aortic Valves (TAVI) - Ongoing Clinical Trials
      • Table figure 5: Transcatheter Aortic Valves (TAVI) - Ongoing Clinical Trials
      • Table Transcatheter Aortic Valves (TAVI) - Ongoing Clinical Trials
  • Transcatheter Aortic Valves (TAVI) - Pipeline Products under Development by Companies
    • Transcatheter Aortic Valves (TAVI) Companies - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valves (TAVI) Companies - Pipeline Products by Stage of Development
    • Transcatheter Aortic Valves (TAVI) - Pipeline Products by Stage of Development
      • Table Transcatheter Aortic Valves (TAVI) - Pipeline Products by Stage of Development
  • Transcatheter Aortic Valves (TAVI) Companies and Product Overview
    • Admedus Ltd Company Overview
      • Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve Replacement - Product Status
        • Table Transcatheter Aortic Valve Replacement - Product Description
    • Aegis Surgical Limited Company Overview
      • Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table pTAo-TAVR - Product Status
        • Table pTAo-TAVR - Product Description
    • Arbor Surgical Technologies, Inc. Company Overview
      • Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trilogy Aortic Valve System - Product Status
        • Table Trilogy Aortic Valve System - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACURATE TAVR - Product Status
        • Table ACURATE TAVR - Product Description
        • Table Gen 4 Lotus Valve System - Product Status
        • Table Gen 4 Lotus Valve System - Product Description
        • Table Lotus Edge Sheath 15F - Product Status
        • Table Lotus Edge Sheath 15F - Product Description
        • Table Lotus Edge Valve System - 21 mm - Product Status
        • Table Lotus Edge Valve System - 21 mm - Product Description
        • Table Lotus Edge Valve System - 23 mm - Product Status
        • Table Lotus Edge Valve System - 23 mm - Product Description
        • Table Lotus Edge Valve System - 25 mm - Product Status
        • Table Lotus Edge Valve System - 25 mm - Product Description
        • Table Lotus Edge Valve System - 27 mm - Product Status
        • Table Lotus Edge Valve System - 27 mm - Product Description
        • Table Lotus Edge Valve System - 29 mm - Product Status
        • Table Lotus Edge Valve System - 29 mm - Product Description
        • Table LOTUS Next Gen - Product Status
        • Table LOTUS Next Gen - Product Description
        • Table Lotus Valve System - 21 mm - Product Status
        • Table Lotus Valve System - 21 mm - Product Description
        • Table Lotus Valve System - 23 mm - Product Status
        • Table Lotus Valve System - 23 mm - Product Description
        • Table Lotus Valve System - 25 mm - Product Status
        • Table Lotus Valve System - 25 mm - Product Description
        • Table Lotus Valve System - 27 mm - Product Status
        • Table Lotus Valve System - 27 mm - Product Description
        • Table Lotus Valve System - 29 mm - Product Status
        • Table Lotus Valve System - 29 mm - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Lotus Valve System - 23 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
        • Table Lotus Valve System - 23 mm - Experience with Percutaneous Transcatheter Aortic Valve Implantation in Patients with Symptomatic Aortic Valve Disease in Two German Centers
        • Table Lotus Valve System - 23 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
        • Table Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
        • Table Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with a Flexible Delivery System - Confirmation of Performance and Safety:REPRISE II FLEX
        • Table Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 27 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
        • Table Lotus Valve System - 27 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
        • Table Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with a Flexible Delivery System - Confirmation of Performance and Safety:REPRISE II FLEX
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with the Next Generation Delivery System (REPRISE NGDS)
        • Table Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 25 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
        • Table Lotus Valve System - 25 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
        • Table Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
        • Table Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 21 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
        • Table Lotus Valve System - 21 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
        • Table Lotus Valve System - 21 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 21 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 29 mm - Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
        • Table Lotus Valve System - 29 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
        • Table Lotus Valve System - 29 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 29 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Edge Valve System - 23 mm - Randomized Comparison of Repositionable and Balloon- Expandable Prostheses in Patients Undergoing Trans-catheter Aortic Valve Implantation
        • Table Lotus Edge Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with the Next Generation Delivery System (REPRISE NGDS)
        • Table Lotus Edge Valve System - 23 mm - REPRISE EDGE: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System - Evaluation of Performance and Safety
        • Table Lotus Edge Valve System - 29 mm - Reprise Edge 29 Mm Eu Study: Repositionable Percutaneous Replacement of Native Stenotic Aortic Valve Through Implantation of Lotus Edge 29 Mm Valve - Evaluation of Safety and Performance
        • Table Lotus Edge Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with the Next Generation Delivery System (REPRISE NGDS)
        • Table Lotus Edge Valve System - 25 mm - REPRISE EDGE: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System - Evaluation of Performance and Safety
        • Table Lotus Edge Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve with the Next Generation Delivery System (REPRISE NGDS)
        • Table Lotus Edge Valve System - 27 mm - REPRISE EDGE: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System - Evaluation of Performance and Safety
    • Clemson University Company Overview
      • Clemson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clemson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Bioprosthetic Heart Valve - Product Status
        • Table Transcatheter Bioprosthetic Heart Valve - Product Description
    • Colibri Heart Valve, LLC Company Overview
      • Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri Aortic Heart Valve - 24mm - Product Status
        • Table Colibri Aortic Heart Valve - 24mm - Product Description
        • Table Colibri Aortic Heart Valve - 21mm - Product Status
        • Table Colibri Aortic Heart Valve - 21mm - Product Description
        • Table Colibri Aortic Heart Valve - 27mm - Product Status
        • Table Colibri Aortic Heart Valve - 27mm - Product Description
        • Table Colibri TAVI System - Product Status
        • Table Colibri TAVI System - Product Description
        • Table Delta Aortic Heart Valve - Product Status
        • Table Delta Aortic Heart Valve - Product Description
        • Table Venibri Transcatheter Heart Valve System - Product Status
        • Table Venibri Transcatheter Heart Valve System - Product Description
    • Daidalos Solutions BV Company Overview
      • Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Status
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Description
    • Direct Flow Medical Inc Company Overview
      • Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Status
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Description
        • Table 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Status
        • Table 23mm Direct Flow Medical Transcatheter Aortic Valve System - Product Description
        • Table Direct Flow Medical Inc - Ongoing Clinical Trials Overview
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System for the Treatment of Patients with Severe Aortic Stenosis
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - SALUS Trial Transcatheter Aortic Valve Replacement System Pivotal Trial the Safety and Effectiveness of the Direct Flow Medical Tanscatheter
    • DSM Dyneema B.V. Company Overview
      • DSM Dyneema B.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSM Dyneema B.V. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Status
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Description
    • Edwards Lifesciences Corp Company Overview
      • Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edwards CENTERA Valve - Product Status
        • Table Edwards CENTERA Valve - Product Description
        • Table Edwards SAPIEN 3 Transcatheter Heart Valve - Low Risk - Product Status
        • Table Edwards SAPIEN 3 Transcatheter Heart Valve - Low Risk - Product Description
        • Table Next Gen CENTERA - Product Status
        • Table Next Gen CENTERA - Product Description
        • Table Next Gen SAPIEN - Product Status
        • Table Next Gen SAPIEN - Product Description
        • Table Sapien 3 Heart Valve - Heart Failure - Product Status
        • Table Sapien 3 Heart Valve - Heart Failure - Product Description
        • Table Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
        • Table Edwards CENTERA Valve - Safety and Performance Study of the Edwards CENTERA Self- Expanding Transcatheter Heart Valve
        • Table Edwards CENTERA Valve - Safety and Performance Study of the Edwards CENTERA-EU Selfexpanding Transcatheter Heart Valve
        • Table Sapien 3 Heart Valve - Heart Failure - Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD)
        • Table Edwards SAPIEN 3 Transcatheter Heart Valve - Low Risk - A Prospective, Randomized, Controlled, Multi-center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
        • Table Edwards SAPIEN 3 Transcatheter Heart Valve - Low Risk - Mitral Valve in Valve is a Prospective, Single-arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3 Transcatheter Heart Valve Implantation in Patients with a Failing Mitral Bioprosthetic Valve: PARTNER 3 Trial
    • Hansen Medical Inc Company Overview
      • Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTx Valve - Product Status
        • Table AorTx Valve - Product Description
    • HLT, Inc. Company Overview
      • HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLT Transcatheter Valve System - Product Status
        • Table HLT Transcatheter Valve System - Product Description
        • Table HLT, Inc. - Ongoing Clinical Trials Overview
        • Table HLT Transcatheter Valve System - Transfemoral Replacement of Aortic Valve with HLT Meridian Valve Early Feasibility Trial
        • Table HLT Transcatheter Valve System - Transfemoral Replacement of Aortic Valve with HLT Meridian Valve Feasibility Trial Canada
    • JC Medical, Inc. Company Overview
      • JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table J-Valve Ausper TAVI System - Product Status
        • Table J-Valve Ausper TAVI System - Product Description
        • Table JC Medical, Inc. - Ongoing Clinical Trials Overview
        • Table J-Valve Ausper TAVI System - Clinical Performance of JC Medical TAVI System in Chinese Subjects with Heart Failure
        • Table J-Valve Ausper TAVI System - Clinical Performance of JC Medical TAVI System in Subjects with Heart Failure
        • Table J-Valve Ausper TAVI System - Efficacy and Safety Evaluation for the Interventional Aortic Valve Bioprosthesis and Delivery System in Patients with Severe Aortic Stenosis and/or Aortic Regurgitation with Elevated Surgical Risk
    • JenaValve Technology GmbH Company Overview
      • JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - Product Status
        • Table JenaValve Pericardial TAVR System - Product Description
        • Table JenaValve Technology GmbH - Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - Safety and Effectiveness/Performance of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation (AR)
        • Table JenaValve Pericardial TAVR System - Safety and Effectiveness/Performance of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS)
    • Mayo Clinic US Company Overview
      • Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Aortic Valve - Product Status
        • Table Percutaneous Aortic Valve - Product Description
    • Medtronic plc Company Overview
      • Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CoreValve Evolut R Recapturable System - Low-Risk Aortic Stenosis - Product Status
        • Table CoreValve Evolut R Recapturable System - Low-Risk Aortic Stenosis - Product Description
        • Table TCV - Aortic - Product Status
        • Table TCV - Aortic - Product Description
        • Table Medtronic plc - Ongoing Clinical Trials Overview
        • Table CoreValve Evolut R Recapturable System - Low-Risk Aortic Stenosis - Transcatheter Aortic Valve Replacement with the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
    • Meril Life Sciences Pvt Ltd Company Overview
      • Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Myval Transcatheter Aortic Valve Replacement System - Product Status
        • Table Myval Transcatheter Aortic Valve Replacement System - Product Description
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitaflow Transcatheter Aortic Valve - Product Status
        • Table Vitaflow Transcatheter Aortic Valve - Product Description
        • Table MicroPort Scientific Corp - Ongoing Clinical Trials Overview
        • Table Vitaflow Transcatheter Aortic Valve - Clinical Evaluation of the Safety and Performance of the MicroPort's Transcatheter Aortic Valve and Delivery System for Treatment of Severe Aortic Stenosis
    • PolyNova Cardiovascular LLC (Inactive) Company Overview
      • PolyNova Cardiovascular LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyNova Cardiovascular LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Status
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Description
    • RegenaGraft Company Overview
      • RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synthetic Heart Valve - Product Status
        • Table Synthetic Heart Valve - Product Description
    • ReValve Med Inc Company Overview
      • ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Aortic Valve - Product Status
        • Table Removable Transcatheter Aortic Valve - Product Description
    • SAS Cormove Company Overview
      • SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table CORMOVE Percutaneous Aortic Valve - Product Status
        • Table CORMOVE Percutaneous Aortic Valve - Product Description
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation - Portico Valve - Product Status
        • Table Next Generation - Portico Valve - Product Description
        • Table Portico Transcatheter Aortic Valve Implantation System - Product Status
        • Table Portico Transcatheter Aortic Valve Implantation System - Product Description
        • Table St. Jude Medical LLC - Ongoing Clinical Trials Overview
        • Table Portico Transcatheter Aortic Valve Implantation System - Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alternative Access
        • Table Portico Transcatheter Aortic Valve Implantation System - International International Long-term Follow-up Study Of Patients Implanted with A Portico Valve
        • Table Portico Transcatheter Aortic Valve Implantation System - Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
    • Symetis AG Company Overview
      • Symetis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symetis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACURATE neo AS - Product Status
        • Table ACURATE neo AS - Product Description
        • Table ACURATE neo TF - Product Status
        • Table ACURATE neo TF - Product Description
        • Table ACURATE TAo - Product Status
        • Table ACURATE TAo - Product Description
        • Table Acurate TF - Product Status
        • Table Acurate TF - Product Description
        • Table Symetis AG - Ongoing Clinical Trials Overview
        • Table Acurate TF - ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neo AS TF Transfemoral Delivery System in Patients with Severe Aortic Stenosis
        • Table Acurate TF - Prospective Observation of Aortic Regurgitation after TAVI and Progress over Time: Progress PVL Registry
        • Table Acurate TF - Safety and Efficacy of SYM-SV/DS-002 in Patients with Severe Aortic Stenosis
        • Table Acurate TF - Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis for Transcatheter Aortic Valve Implantation by Transfemoral Approach
        • Table ACURATE neo TF - Acurate Neo Aortic Bioprosthesis for Implantation Using the Acurate Neo TA Transapical Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo TF - ACURATE Neo Aortic Bioprosthesis for Implantation Using the ACURATE TA LP Transapical Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo TF - ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neo AS TF Transfemoral Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo TF - Prospective Observation of Aortic Regurgitation after TAVI and Progress over Time: Progress PVL Registry
        • Table ACURATE neo TF - Safety and Efficacy Comparison of Two TAVI Systems in a Prospective Randomized Evaluation II: A Randomized, Controlled, Non-inferiority Trial Evaluating Safety and Clinical Efficacy of the Symetis ACURATE Neo Compared to the Medtronic Evolut R Bioprosthesis in Transfemoral Transcatheter Aortic Valve Implantation
        • Table ACURATE neo TF - Safety and Efficacy of SYM-SV/DS-002 in Patients with Severe Aortic Stenosis
        • Table ACURATE neo TF - Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis for Transcatheter Aortic Valve Implantation by Transfemoral Approach
        • Table ACURATE neo AS - ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neo AS TF Transfemoral Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo AS - Safety and Efficacy Comparison of Two TAVI Systems in a Prospective Randomized Evaluation II: A Randomized, Controlled, Non-inferiority Trial Evaluating Safety and Clinical Efficacy of the Symetis ACURATE Neo Compared to the Medtronic Evolut R Bioprosthesis in Transfemoral Transcatheter Aortic Valve Implantation
    • Thubrikar Aortic Valve, Inc. Company Overview
      • Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optimum TAVI System - Product Status
        • Table Optimum TAVI System - Product Description
    • University College London Company Overview
      • University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRISKELE Aortic Valve - Product Status
        • Table TRISKELE Aortic Valve - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve - Product Status
        • Table Transcatheter Aortic Valve - Product Description
    • University of Cambridge Company Overview
      • University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Valve - Product Status
        • Table Removable Transcatheter Valve - Product Description
    • University of Iowa Company Overview
      • University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellulose Based Aortic Heart Valve - Product Status
        • Table Cellulose Based Aortic Heart Valve - Product Description
    • Vascular Concepts Ltd Company Overview
      • Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Status
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Description
    • Venus MedTech Company Overview
      • Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
        • Table Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transapical Trinity Aortic Valve Implantation System - Product Status
        • Table Transapical Trinity Aortic Valve Implantation System - Product Description
        • Table Venus A-Valve - Product Status
        • Table Venus A-Valve - Product Description
        • Table Venus MedTech - Ongoing Clinical Trials Overview
        • Table Venus A-Valve - Clinical Evaluation of the Safety and Performance of Percutaneous Implantation of the Venus MedTech Aortic Valve Prosthesis for Patients Who Cannot Undergo Surgical Valve Replacement
    • Xeltis AG Company Overview
      • Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Heart Valve - Product Status
        • Table Transcatheter Aortic Heart Valve - Product Description
  • Transcatheter Aortic Valves (TAVI)- Recent Developments
    • Oct 26, 2017: HLT to Provide Clinical Update at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) Conference
    • Oct 26, 2017: MicroPort CardioFlow Attends 2017 PCR London Valves
    • Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
    • Oct 24, 2017: Admedus TAVR Project on Track with New IP Applications
    • Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
    • Oct 23, 2017: Boston Scientific Presents Study Results of ACURATE neo Aortic Valve System at Transcatheter Cardiovascular Therapeutics 2017
    • Oct 23, 2017: Boston Scientific Presents Study Results of Lotus Aortic Valve System at Transcatheter Cardiovascular Therapeutics 2017
    • Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
    • Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
    • Sep 21, 2017: Medtronic Announces Clinical Study to Evaluate the CoreValve Evolut PRO System in 'Everyday' Clinical Practice
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Jul 31, 2017: Medtronic Announces CE Mark and European Launch of CoreValve Evolut PRO Transcatheter Valve with Advanced Sealing
    • Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
    • Jul 10, 2017: Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval
    • Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
    • Jun 06, 2017: First U.S. Patients Enrolled in an Early Feasibility Study of HLT's New Transcatheter Aortic Valve Replacement System
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 17, 2017: Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
    • May 16, 2017: Real-World Evidence With Edwards SAPIEN 3 Transcatheter Valve Confirms Beneficial Patient Outcomes From Clinical Trials
    • May 16, 2017: The Boston Scientific LOTUS Valve System Demonstrated Superior Efficacy to CoreValve in Global REPRISE III Trial at One Year
    • May 16, 2017: New Data on CoreValve and Evolut R Self-Expanding TAVI Systems Show Excellent Clinical Outcomes in Routine Clinical Practice
    • Apr 28, 2017: Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China English
    • Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
    • Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
    • Apr 05, 2017: Aurora Health Care Heart Experts Among First in Nation to Implant New Heart Valve to Treat Aortic Stenosis
    • Apr 04, 2017: HLT Announces First Patient Enrollments in a Feasibility Study of a New Transcatheter Aortic Valve Replacement System
    • Mar 22, 2017: Medtronic Receives FDA Approval for CoreValve Evolut Pro Transcatheter Valve with Advanced Sealing
    • Mar 17, 2017: Landmark SURTAVI Clinical Trial Shows Transcatheter Aortic Valve Replacement with the Self-Expanding Platform Performs as Well as Surgery in Intermediate Risk Severe Aortic Stenosis Patients
    • Mar 09, 2017: Boston Scientific Receives Favorable Rulings In Edwards Lifesciences Litigation
    • Mar 03, 2017: Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification
    • Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
    • Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
    • Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
    • Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results
    • Jan 17, 2017: Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies
    • Dec 26, 2016: MicroPort Completes Patient Enrollment of VitaFlow Pre-market Clinical Trial
    • Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
    • Dec 01, 2016: Medtronic Announces Reimbursement Approval and Launch of CoreValve Evolut R System in Japan
    • Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
    • Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
    • Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report